TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 5,500.00
-70.00 (-1.26%)
At close: Jan 27, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 182.28 billion as of January 29, 2026. Its market cap has increased by 62.38% in one year.
Market Cap
182.28B
Enterprise Value
185.27B
Revenue
9.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,500.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 182.28B, a decrease of -41.56%. That is a compound annual growth rate of -8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 182.28B | 6.85% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 215.61B |
| Kangstem Biotech | 198.45B |
| Bio Solution | 192.65B |
| curacle co.,ltd. | 186.56B |
| ViGenCell | 172.60B |
| QuadMedicine | 167.40B |
| CORESTEMCHEMON | 162.58B |
| NovMetaPharma | 156.33B |